It is important to screen men according to age, history and PSA values as it is the most common cancer in men over 70 in Europe and causes 3% of deaths in men in the European Union. It is rare in men under 50 years of age and the mortality rate in men under 60 years of age is low. In Spain, around 80 cases/100,000 inhabitants are diagnosed annually, with 711 PT3T over 65 years of age. Screening is associated with a higher diagnosis of prostate cancer and an earlier stage at diagnosis without increasing overall survival, according to the latest studies.